Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Muzyczka

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Journal of Virology|July 23, 2002
Studies of the mechanism of transactivation of the adeno-associated virus p19 promoter by Rep proteinDaniel F Lackner, Nicholas Muzyczka
Human Gene Therapy|May 6, 2005
Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropismNicholas Muzyczka, Kenneth H Warrington
Human Gene Therapy|March 25, 2017
AAV: An Overview of Unanswered QuestionsKenneth I Berns, Nicholas Muzyczka
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2015
AAV's Golden JubileeNicholas Muzyczka, Kenneth I Berns
Annual Review of Virology|March 10, 2016
AAV-Mediated Gene Therapy for Research and Therapeutic PurposesR Jude Samulski, Nicholas Muzyczka
Journal of Virology|December 7, 2007
Complete in vitro reconstitution of adeno-associated virus DNA replication requires the minichromosome maintenance complex proteinsKevin Nash, Weijun Chen, Nicholas Muzyczka
Journal of Virology|October 31, 2008
Identification of cellular proteins that interact with the adeno-associated virus rep proteinKevin Nash, Weijun Chen, Max Salganik, et al.
Cancer Gene Therapy|May 29, 2002
Adeno-associated virus-mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivoWenyin Shi, Christian Teschendorf, Nicholas Muzyczka, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 2003
Gene therapy delivery of endostatin enhances the treatment efficacy of radiationWenyin Shi, Christian Teschendorf, Nicholas Muzyczka, et al.
Journal of Virology|May 28, 2004
Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brainCarmen S Peden, Corinna Burger, Nicholas Muzyczka, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Journal of Virology|July 23, 2002
Studies of the mechanism of transactivation of the adeno-associated virus p19 promoter by Rep proteinDaniel F Lackner, Nicholas Muzyczka
Human Gene Therapy|May 6, 2005
Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropismNicholas Muzyczka, Kenneth H Warrington
Human Gene Therapy|March 25, 2017
AAV: An Overview of Unanswered QuestionsKenneth I Berns, Nicholas Muzyczka
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2015
AAV's Golden JubileeNicholas Muzyczka, Kenneth I Berns
Annual Review of Virology|March 10, 2016
AAV-Mediated Gene Therapy for Research and Therapeutic PurposesR Jude Samulski, Nicholas Muzyczka
Journal of Virology|December 7, 2007
Complete in vitro reconstitution of adeno-associated virus DNA replication requires the minichromosome maintenance complex proteinsKevin Nash, Weijun Chen, Nicholas Muzyczka
Journal of Virology|October 31, 2008
Identification of cellular proteins that interact with the adeno-associated virus rep proteinKevin Nash, Weijun Chen, Max Salganik, et al.
Cancer Gene Therapy|May 29, 2002
Adeno-associated virus-mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivoWenyin Shi, Christian Teschendorf, Nicholas Muzyczka, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 2003
Gene therapy delivery of endostatin enhances the treatment efficacy of radiationWenyin Shi, Christian Teschendorf, Nicholas Muzyczka, et al.
Journal of Virology|May 28, 2004
Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brainCarmen S Peden, Corinna Burger, Nicholas Muzyczka, et al.
Pageof 9